Compounds > n-methylepinephrine
Page last updated: 2024-12-05

n-methylepinephrine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methylepinephrine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11139
SCHEMBL ID521779
MeSH IDM0045877

Synonyms (45)

Synonym
n-methyladrenaline
wln: qr bq dyq1n1&1
benzyl alcohol,4-dihydroxy-
.alpha.-(3,4-dihydroxyphenyl)-(.beta.-dimethylamino)ethanol
3,4-dihydroxy-.alpha.-(dimethylaminomethyl)benzyl alcohol
.alpha.-(3,4-dihydroxyphenyl)-.beta.-dimethylaminoethanol
nsc169812
3,4-dihydroxy-.alpha.-[(dimethylamino)methyl] benzyl alcohol
.alpha.-[(dimethylamino)methyl]protocatechuyl alcohol
.alpha.-(dimethylaminomethyl)protocatechuyl alcohol
methadrene
n-methylepinephrine
.alpha.-(3,4-dihydroxyphenyl)-.alpha.-hydroxy-(.beta.-dimethylamino)ethane
554-99-4
nsc-169812
1, 4-[2-(dimethylamino)-1-hydroxyethyl]-
1,2-benzenediol, 4-(2-(dimethylamino)-1-hydroxyethyl)-
alpha-(3,4-dihydroxyphenyl)-beta-dimethylaminoethanol
3,4-dihydroxy-alpha-(dimethylaminomethyl) benzyl alcohol
3,4-dihydroxy-alpha-(dimethylaminomethyl)benzyl alcohol
einecs 209-078-2
nsc 169812
alpha-(3,4-dihydroxyphenyl)-alpha-hydroxy-beta-dimethylaminoethane
4-(2-(dimethylamino)-1-hydroxyethyl)pyrocatechol
alpha-(dimethylaminomethyl)protocatechuyl alcohol
benzyl alcohol, alpha-((dimethylamino)methyl)-3,4-dihydroxy-
protocatechuyl alcohol, alpha-((dimethylamino)methyl)-
4-[2-(dimethylamino)-1-hydroxyethyl]benzene-1,2-diol
unii-t12bo931w4
t12bo931w4 ,
SCHEMBL521779
6032-14-0
methadren(e)
dl-n-methylepinephrine
1,2-benzenediol, 4-(2-(dimethylamino)-1-hydroxyethyl)-)
n-methylepinephrine dl-form [mi]
benzyl alcohol, .alpha.-((dimethylamino)methyl)-3,4-dihydroxy-
1,2-benzenediol, 4-[2-(dimethylamino)-1-hydroxyethyl]-
protocatechuyl alcohol, .alpha.-((dimethylamino)methyl)-
RLATYNCITHOLTJ-UHFFFAOYSA-N
4-[2-(dimethylamino)-1-hydroxyethyl]-1,2-benzenediol #
4-[2-(dimethylamino)-1-hydroxyethyl]pyrocatechol
rac n-methyl epinephrine
Q27289528
DTXSID50871762
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.36 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
ConditionIndicatedRelationship StrengthStudiesTrials
Aging
The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.		03.3711
Adrenal Cancer
[description not available]		01.9710
Blood Pressure, High
[description not available]		01.9710
Pheochromocytoma, Extra-Adrenal
[description not available]		01.9710
Hypertension
Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.		01.9710
Pheochromocytoma
A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)		01.9710